Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5
Sanofi
Javier Cortés; Sara A Hurvitz; Joyce O'Shaughnessy; Suzette Delaloge; Hiroji Iwata; Hope S Rugo; Patrick Neven; Dheepak Kanagavel; Patrick Cohen; Gautier Paux; Sylvaine Cartot-Cotton; Maya Stefanova-Urena; Laure Deyme; Jihane Aouni; Bernard Sebastien; Aditya Bardia